HBI Deals+Insights / M&A/IPOs

EQT fully exits dermatology company Galderma

Swedish private equity firm EQT has fully exited Swiss pure-play dermatology company Galderma through a CHF 4.9 billion (~$6.21 billion) block trade. EQT and its co-investors, including sovereign wealth funds Abu Dhabi Investment Authority (ADIA) and GIC (Singapore), sold their remaining 14.3% stake (around 34 million shares). EQT VIII is expected to receive approximately CHF 1.3 billion (~$1.65 billion).